Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2017

Oct 3, 2017

32106_dirs_2017-10-03_7c674031-bcbe-4f04-a255-c05286e4d2ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2017-10-03

Reporting Person: COHEN RAYMOND W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-10-03 Common Stock A 3325 Acquired 58068 Direct

Footnotes

F1: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $18,750 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter.